[New OTC Market’s innovation layer echelon iteration speeds up, and multiple capital paths help high-quality companies to improve.] September 17th, since this year, the New OTC Board’s innovation layer echelon iteration pace has accelerated, and high-quality companies have continued to gather. The National Equities Exchange and Quotations recently released the fourth batch of preliminary screening lists for the innovation level. 12 companies including Meitong Aromatherapy, Goodeng Machinery, and Bondi Intelligence were selected, covering high-end manufacturing, new materials, digital economy and other tracks. So far, a total of more than 220 enterprises have been planned to be transferred to the innovation level this year, five of which will become national-level specialized and new "little giant" enterprises, and manufacturing enterprises account for more than 80%, covering key fields such as electrical machinery, special equipment, auto parts, electronic communications, etc., which are highly consistent with the development direction of new industrialization and new quality productivity. As of September 15, the total number of innovative companies on the New Third Board reached 2,274. From the perspective of profit quality, the average revenue and net profit of new entrants in 2025 will maintain double-digit growth, and more than 40% of companies will see net profit growth exceeding 30%. They have both hard technological attributes and growth resilience, and the overall quality of the echelon continues to improve. (Shanghai Securities News)